|
Allot Ltd.
By: /s/ Ziv Leitman
Ziv Leitman
Chief Financial Officer
|
Exhibit Number
|
Description
|
•
|
First quarter revenues were $29.3 million, up 16% year-over-year;
|
•
|
Non-GAAP gross margin increased to 74.8% compared to 72.4% in the first quarter of 2019 and GAAP gross margin increased to 74.0% compared to 71.2% in the first quarter of 2019;
|
•
|
Non-GAAP net loss of $0.4 million and GAAP net loss $1.7 million, both significantly improved from non-GAAP net loss of $1.9 million and GAAP net loss of $3.3 million in the first quarter
of 2019;
|
•
|
Cash and investments at the end of the first quarter totaled $110.7 million compared to $117.6 million at year-end 2019;
|
•
|
Two additional recurring security revenue deals signed with new operators during the first quarter
|
•
|
Management reiterates its prior issued guidance, with expectations for full year 2020 revenues to grow to between $135-140 million, representing accelerated double-digit growth. In
addition, expectations are that second quarter revenue will exceed those reported for the first quarter of 2020;
|
•
|
Management continues to expect to return to profitability on a quarterly basis before year-end;
|
•
|
Management continues to expect to close additional Recurring Security Revenue deals in 2020 and reiterates that the MAR* (maximum annual revenue potential of concluded transactions) of new
deals expected to be signed in 2020 should exceed $140 million
|
Investor Relations Contact
GK Investor Relations
Ehud Helft
+1 646 201 9246
allot@gkir.com
|
Public Relations Contact
Seth Greenberg, Allot Ltd.
+972 54 922 2294 sgreenberg@allot.com |
TABLE - 1
|
||||||||
ALLOT LTD.
|
||||||||
AND ITS SUBSIDIARIES
|
||||||||
CONSOLIDATED STATEMENTS OF OPERATIONS
|
||||||||
(U.S. dollars in thousands, except share and per share data)
|
||||||||
Three Months Ended
|
||||||||
March 31,
|
||||||||
2020
|
2019
|
|||||||
(Unaudited)
|
(Unaudited)
|
|||||||
Revenues
|
$
|
29,289
|
$
|
25,342
|
||||
Cost of revenues
|
7,610
|
7,293
|
||||||
Gross profit
|
21,679
|
18,049
|
||||||
Operating expenses:
|
||||||||
Research and development costs, net
|
8,699
|
7,174
|
||||||
Sales and marketing
|
11,522
|
11,477
|
||||||
General and administrative
|
3,041
|
2,705
|
||||||
Total operating expenses
|
23,262
|
21,356
|
||||||
Operating loss
|
(1,583
|
)
|
(3,307
|
)
|
||||
Financial and other income, net
|
151
|
532
|
||||||
Loss before income tax expenses
|
(1,432
|
)
|
(2,775
|
)
|
||||
Tax expenses
|
228
|
558
|
||||||
Net Loss
|
(1,660
|
)
|
(3,333
|
)
|
||||
Basic net loss per share
|
$
|
(0.05
|
)
|
$
|
(0.10
|
)
|
||
Diluted net loss per share
|
$
|
(0.05
|
)
|
$
|
(0.10
|
)
|
||
Weighted average number of shares used in
|
||||||||
computing basic net loss per share
|
34,625,632
|
33,983,863
|
||||||
Weighted average number of shares used in
|
||||||||
computing diluted net loss per share
|
34,625,632
|
33,983,863
|
TABLE - 2
|
||||||||
ALLOT LTD.
|
||||||||
AND ITS SUBSIDIARIES
|
||||||||
RECONCILIATION OF GAAP TO NON-GAAP CONSOLIDATED STATEMENTS OF OPERATIONS
|
||||||||
(U.S. dollars in thousands, except per share data)
|
||||||||
Three Months Ended
|
||||||||
March 31,
|
||||||||
2020
|
2019
|
|||||||
(Unaudited)
|
||||||||
GAAP cost of revenues
|
$
|
7,610
|
$
|
7,293
|
||||
Share-based compensation (1)
|
(67
|
)
|
(60
|
)
|
||||
Amortization of intangible assets (2)
|
(152
|
)
|
(232
|
)
|
||||
Non-GAAP cost of revenues
|
$
|
7,391
|
$
|
7,001
|
||||
GAAP gross profit
|
$
|
21,679
|
$
|
18,049
|
||||
Gross profit adjustments
|
219
|
292
|
||||||
Non-GAAP gross profit
|
$
|
21,898
|
$
|
18,341
|
||||
GAAP operating expenses
|
$
|
23,262
|
$
|
21,356
|
||||
Share-based compensation (1)
|
(857
|
)
|
(685
|
)
|
||||
Amortization of intangible assets (2)
|
-
|
(188
|
)
|
|||||
Income (Expenses) related to M&A activities (3)
|
103
|
(295
|
)
|
|||||
Non-GAAP operating expenses
|
$
|
22,508
|
$
|
20,188
|
||||
GAAP financial and other income
|
$
|
151
|
$
|
532
|
||||
Exchange rate differences*
|
218
|
(2
|
)
|
|||||
Non-GAAP Financial and other income
|
$
|
369
|
$
|
530
|
||||
GAAP taxes on income
|
$
|
228
|
$
|
558
|
||||
Tax expenses in respect of net deferred tax asset recorded
|
(60
|
)
|
(16
|
)
|
||||
Non-GAAP taxes on income
|
$
|
168
|
$
|
542
|
||||
GAAP Net Loss
|
$
|
(1,660
|
)
|
$
|
(3,333
|
)
|
||
Share-based compensation (1)
|
924
|
745
|
||||||
Amortization of intangible assets (2)
|
152
|
420
|
||||||
Income (Expenses) related to M&A activities (3)
|
(103
|
)
|
295
|
|||||
Exchange rate differences
|
218
|
(2
|
)
|
|||||
Tax expenses in respect of net deferred tax asset recorded
|
60
|
16
|
||||||
Non-GAAP Net Loss
|
$
|
(409
|
)
|
$
|
(1,859
|
)
|
||
GAAP Loss per share (diluted)
|
$
|
(0.05
|
)
|
$
|
(0.10
|
)
|
||
Share-based compensation
|
0.03
|
0.02
|
||||||
Amortization of intangible assets
|
0.00
|
0.02
|
||||||
Expenses (Income) related to M&A activities
|
(0.00
|
)
|
0.01
|
|||||
Exchange rate differences
|
0.01
|
(0.00
|
)
|
|||||
Non-GAAP Net loss per share (diluted)
|
$
|
(0.01
|
)
|
$
|
(0.05
|
)
|
||
Weighted average number of shares used in
|
||||||||
computing GAAP diluted net loss per share
|
34,625,632
|
33,983,863
|
||||||
Weighted average number of shares used in
|
||||||||
computing non-GAAP diluted net loss per share
|
34,625,632
|
33,983,863
|
||||||
* Financial income or expenses related to exchange rate differences in connection with revaluation of assets and liabilities in non-dollar denominated currencies.
|
TABLE - 2 cont.
|
||||||||
ALLOT LTD.
|
||||||||
AND ITS SUBSIDIARIES
|
||||||||
RECONCILIATION OF GAAP TO NON-GAAP CONSOLIDATED STATEMENTS OF OPERATIONS
|
||||||||
(U.S. dollars in thousands, except per share data)
|
||||||||
Three Months Ended
|
||||||||
March 31,
|
||||||||
2020
|
2019
|
|||||||
(Unaudited)
|
||||||||
(1) Share-based compensation:
|
||||||||
Cost of revenues
|
$
|
67
|
$
|
60
|
||||
Research and development costs, net
|
242
|
169
|
||||||
Sales and marketing
|
378
|
283
|
||||||
General and administrative
|
237
|
233
|
||||||
$
|
924
|
$
|
745
|
|||||
(2) Amortization of intangible assets
|
||||||||
Cost of revenues
|
$
|
152
|
$
|
232
|
||||
Sales and marketing
|
-
|
188
|
||||||
$
|
152
|
$
|
420
|
|||||
(3) Expenses (Income) related to M&A activities
|
||||||||
Research and development costs, net
|
$
|
(103
|
)
|
$
|
295
|
|||
$
|
(103
|
)
|
$
|
295
|
TABLE - 3
|
||||||||
ALLOT LTD.
|
||||||||
AND ITS SUBSIDIARIES
|
||||||||
CONSOLIDATED BALANCE SHEETS
|
||||||||
(U.S. dollars in thousands)
|
||||||||
March 31,
|
December 31,
|
|||||||
2020
|
2019
|
|||||||
(Unaudited)
|
(Audited)
|
|||||||
ASSETS
|
||||||||
CURRENT ASSETS:
|
||||||||
Cash and cash equivalents
|
$
|
29,494
|
$
|
16,930
|
||||
Short-term bank deposits
|
800
|
5,557
|
||||||
Restricted deposit
|
32,156
|
23,183
|
||||||
Available-for-sale marketable securities
|
47,841
|
61,012
|
||||||
Trade receivables, net
|
23,140
|
29,008
|
||||||
Other receivables and prepaid expenses
|
7,589
|
6,528
|
||||||
Inventories
|
15,153
|
10,668
|
||||||
Total current assets
|
156,173
|
152,886
|
||||||
LONG-TERM ASSETS:
|
||||||||
Restricted deposit
|
440
|
10,913
|
||||||
Severance pay fund
|
341
|
387
|
||||||
Operating lease right-of-use assets
|
5,797
|
6,368
|
||||||
Deferred taxes
|
432
|
517
|
||||||
Other assets
|
766
|
926
|
||||||
Total long-term assets
|
7,776
|
19,111
|
||||||
PROPERTY AND EQUIPMENT, NET
|
8,700
|
8,135
|
||||||
GOODWILL AND INTANGIBLE ASSETS, NET
|
34,884
|
35,037
|
||||||
Total assets
|
$
|
207,533
|
$
|
215,169
|
||||
LIABILITIES AND SHAREHOLDERS' EQUITY
|
||||||||
CURRENT LIABILITIES:
|
||||||||
Trade payables
|
$
|
13,944
|
$
|
11,676
|
||||
Deferred revenues
|
29,921
|
36,360
|
||||||
Short-term operating lease liabilities
|
2,951
|
3,151
|
||||||
Other payables and accrued expenses
|
19,885
|
22,255
|
||||||
Total current liabilities
|
66,701
|
73,442
|
||||||
LONG-TERM LIABILITIES:
|
||||||||
Deferred revenues
|
6,075
|
5,262
|
||||||
Long-term operating lease liabilities
|
2,738
|
3,820
|
||||||
Accrued severance pay
|
749
|
794
|
||||||
Total long-term liabilities
|
9,562
|
9,876
|
||||||
SHAREHOLDERS' EQUITY
|
131,270
|
131,851
|
||||||
Total liabilities and shareholders' equity
|
$
|
207,533
|
$
|
215,169
|
TABLE - 4
|
||||||||
ALLOT LTD.
|
||||||||
AND ITS SUBSIDIARIES
|
||||||||
CONSOLIDATED STATEMENTS OF CASH FLOWS
|
||||||||
(U.S. dollars in thousands)
|
||||||||
Three Months Ended
|
||||||||
March 31,
|
||||||||
2020
|
2019
|
|||||||
(Unaudited)
|
(Unaudited)
|
|||||||
Cash flows from operating activities:
|
||||||||
Net Loss
|
$
|
(1,660
|
)
|
$
|
(3,333
|
)
|
||
Adjustments to reconcile net income to net cash used in operating activities:
|
||||||||
Depreciation
|
788
|
616
|
||||||
Stock-based compensation related to options granted to employees
|
924
|
745
|
||||||
Amortization of intangible assets
|
152
|
420
|
||||||
Increase (Decrease) in accrued severance pay, net
|
1
|
(65
|
)
|
|||||
Decrease in other assets
|
160
|
67
|
||||||
Decrease in accrued interest and amortization of premium on marketable securities
|
171
|
77
|
||||||
Changes in operating leases, net
|
(711
|
)
|
(206
|
)
|
||||
Decrease (Increase) in trade receivables
|
5,868
|
(2,593
|
)
|
|||||
Increase in other receivables and prepaid expenses
|
(401
|
)
|
(1,147
|
)
|
||||
Increase in inventories
|
(4,485
|
)
|
(1,910
|
)
|
||||
Decrease (Increase) in long-term deferred taxes, net
|
84
|
(33
|
)
|
|||||
Increase in trade payables
|
2,268
|
2,557
|
||||||
Increase (Decrease) in employees and payroll accruals
|
(1,325
|
)
|
1,023
|
|||||
Decrease in deferred revenues
|
(5,626
|
)
|
(592
|
)
|
||||
Increase (Decrease) in other payables, accrued expenses and other long term liabilities
|
(1,718
|
)
|
1,893
|
|||||
Net cash used in operating activities
|
(5,510
|
)
|
(2,481
|
)
|
||||
Cash flows from investing activities:
|
||||||||
Decrease (Increase) in restricted deposit
|
1,500
|
(83
|
)
|
|||||
Redemption of short-term deposits
|
4,757
|
3,986
|
||||||
Purchase of property and equipment
|
(1,351
|
)
|
(729
|
)
|
||||
Investment in available-for sale marketable securities
|
(375
|
)
|
(11,584
|
)
|
||||
Proceeds from redemption or sale of available-for sale marketable securities
|
12,923
|
11,379
|
||||||
Net cash provided by investing activities
|
17,454
|
2,969
|
||||||
Cash flows from financing activities:
|
||||||||
Exercise of employee stock options
|
620
|
606
|
||||||
Net cash provided by financing activities
|
620
|
606
|
||||||
Increase in cash and cash equivalents
|
12,564
|
1,094
|
||||||
Cash and cash equivalents at the beginning of the period
|
16,930
|
16,336
|
||||||
Cash and cash equivalents at the end of the period
|
$
|
29,494
|
$
|
17,430
|